Similar results were obtained in vivo when PD brain- or symptomatic α-synuclein transgenic mice-derived homogenates were delivered in the living brains of mice and monkeys (Mougenot et al., 2012; Recasens et al., 2014; Schweighauser et al., 2015). Here, SNCA is linked to Parkinson disease.